← Browse by Condition
Medical Condition
acute lymphoblastic leukemia in remission
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 1, Phase 2
NCT05794880
Recruiting
MCW Alpha/Beta T-Cell and B-Cell Depletion With Targeted ATG Dosing
Enrollment
40 pts
Location
United States
Sponsor
Medical College of Wisconsin
NCT03670966 Phase 1, Phase 2
Recruiting
211At-BC8-B10 Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory High-Risk Acute Leukemia or Myelodysplastic Syndrome
Enrollment
30 pts
Location
United States
Sponsor
Fred Hutchinson Cancer Center